Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease

So-Ryoung Lee; Hyun‐Jung Lee; Eue-Keun Choi; Kyungdo Han; Jin‐Hyung Jung; Myung‐Jin Cha; Seil Oh; Professor Gregory Lip

doi:10.1016/j.jacc.2019.04.052

Related publications

Editorial Material2023

Use of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Liver Disease

Theresa Hydes, Professor Gregory Lip, Deirdre A. Lane

Article2019

P4789Comparisons of direct oral anticoagulants and warfarin in patients with atrial fibrillation and liver cirrhosis

Tze‐Fan Chao, Professor Gregory Lip, S A Chen

Article2020

Direct Oral Anticoagulants in Atrial Fibrillation Patients With Concomitant Hyperthyroidism

Yi‐Hsin Chan, Lung‐Sheng Wu, Lai‐Chu See, Jia‐Rou Liu, Shang‐Hung Chang, Tze‐Fan Chao, Yung‐Hsin Yeh, Chi‐Tai Kuo, Hsin‐Fu Lee, Professor Gregory Lip

Article2023

Gastrointestinal bleeding with direct oral anticoagulants in patients with atrial fibrillation and anaemia

Nour R. Al‐Hussainy, Kristian Kragholm, Søren Lundbye‐Christensen, Christian Torp‐Pedersen, Manan Pareek, Susette Krohn Therkelsen, Professor Gregory Lip, Sam Riahi

Article2021

Direct oral anticoagulants in patients with nonvalvular atrial fibrillation and extreme body weight

Francesca Bodega, Anita Russi, Francesco Melillo, Fabiana Blunda, Claudia Rubino, Giulio Leo, Alberto Cappelletti, Patrizio Mazzone, Paolo Mattiello, Paolo Della Bella, Alessandro Castiglioni, Ottavio Alfieri, Michele De Bonis, Matteo Montorfano, Moreno Tresoldi, Massimo Filippi, Anna Salerno, Michela Cera, Alberto Zangrillo, Alberto Margonato, Cosmo Godino

Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease

Discussion(0)